Aurobindo Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?
AUROBINDO PHARMA has four hundred and seventy-six approved drugs.
There are nineteen tentative approvals on AUROBINDO PHARMA drugs.
Summary for Aurobindo Pharma
US Patents: | 0 |
Tradenames: | 368 |
Ingredients: | 342 |
NDAs: | 476 |
Patent Litigation for Aurobindo Pharma: | See patent lawsuits for Aurobindo Pharma |
PTAB Cases with Aurobindo Pharma as petitioner: | See PTAB cases with Aurobindo Pharma as petitioner |
Drugs and US Patents for Aurobindo Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Ltd | FEBUXOSTAT | febuxostat | TABLET;ORAL | 210741-001 | Oct 25, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Ltd | DOFETILDE | dofetilide | CAPSULE;ORAL | 210740-002 | Jan 22, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 090871-001 | Jun 7, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Usa | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 202640-003 | Sep 17, 2012 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 203962-001 | Jun 11, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 077376-004 | Feb 28, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 203367-004 | Feb 2, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.